E2 modulates mitochondrial function through both genomic and non-genomic pathways, positioning mitochondria as key mediators of hormonal effects on brain health
Immunity IV Strengthens immune defenses and supports recovery
doi: 10.2337/db08-0593 [DOI] [PMC free article] [PubMed] [Google Scholar] 30.Pittas AG, Dawson-Hughes B, Sheehan P, et al
Clinically Important Drug Interactions with PPIs Reduced absorption due to gastric pH Azoles: Ketoconazole, Itraconazole, Posaconazole (oral) Antiretrovirals: Atazanavir , Rilpivirine Oral anticancer drugs (pH-dependent) Erlotinib, Gefitinib, Dasatinib, Nilotinib Iron salts, Calcium carbonate Mycophenolate mofetil Increased exposure / toxicity High-dose Methotrexate delayed clearance & toxicity Warfarin INR (monitor closely) Phenytoin, Diazepam Long-term safety concerns Hypomagnesemia (higher risk with diuretics) Clostridioides difficile infection Fracture risk with prolonged use Clinical Pearl Avoid unnecessary PPIs in patients receiving pH-dependent oral anticancer therapies
Cultivating a Safety -First Culture Within Research Organizations A safety -first culture is cultivated when every member of a research organization from clinicians to administrative personnelembraces the core principle that patient safety is paramount
